| Recent MNPR Stock Price | MNPR Stock Predictions | |
| $77.05 | ![]() +43.41% |
$110.50 |
| Recent MNPR Analyst Ratings Breakdown, Making MNPR Stock Predictions | ||||
|---|---|---|---|---|
| Current | 1 Mo. Ago | 2 Mo. Ago | 3 Mo. Ago | |
| Strong buy ratings: | 11 | 12 | 10 | 8 |
| Buy ratings: | 1 | 0 | 0 | 0 |
| Hold ratings: | 1 | 1 | 1 | 2 |
| Sell ratings: | 0 | 0 | 0 | 0 |
| Strong sell ratings: | 0 | 0 | 0 | 0 |
| Average rating: | 1.23 | 1.15 | 1.18 | 1.4 |
For the MNPR stock predictions from the analysts covering Monopar Therapeutics Inc, we have collected all of the individual MNPR stock predictions for stock price one year from now (i.e. each analyst's "forward price target") and at the top of this page we have presented the average prediction across the 12 different analysts covering MNPR (as reported in
data provided by Zacks Investment Research via Quandl.com).
But since MNPR stock predictions may vary widely, another useful metric to consider is the median MNPR stock prediction, which represents the price at which half of the analysts
made MNPR stock predictions that were higher and half made MNPR stock predictions that were lower. This makes for a different take on the MNPR stock predictions out there, as compared to average or mean.
And that median across all the individual MNPR stock predictions was: $107.5 as of 2025-12-12.
The very highest of the MNPR stock predictions for one year price target was $130.0, while the very lowest of the MNPR stock predictions in the analyst group was
$93.0 (with a standard deviation of $11.237). Get the latest Zacks research report on MNPR — FREE
Find out: MNPR next earnings date »
Dividend Growth Stocks: 25 Aristocrats
10 Dividend Bargains You Can Buy Cheaper Than Insiders Did
Other stock predictions:
APTV Stock Predictions
PPC Stock Predictions
AXL Stock Predictions
BELFB Stock Predictions
ALPN Stock Predictions
IDXX Stock Predictions
RL Stock Predictions
GME Stock Predictions
AIN Stock Predictions
|
|||||||||
Strong Buy (3.77 out of 4) 96th percentile
(ranked higher than approx. 96% of all stocks covered)
Based on data provided by Zacks Investment Research via Quandl.com |